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Smith, and ourselves. The reviews collectively indicate that your experiments generated new and important information. However, there are several issues that need to be clarified/resolved before we can consider your manuscript further for publication in EJN.
As you can see below, the three reviewers found significant merit to your study and consider that your findings are relevant to the field. However, two of them raised a few important points you need to pay attention to in the revised manuscript. The following issues are particularly relevant. 1) Please, clarify the presentation of data in figure 1 to address the concerns raised by one of the reviewers.
2) The rationale to look at ASIC2 instead of ASIC1 mRNA must be strengthened. 3) Describe in more detail the data collection approach for the behavioral experiments, paying a particular attention to the blinding of the observers to the animal genotype. We concur with the reviewer that the investigators must be blinded to the animal genotype. If this was not the case, it must be mentioned and caveats raised. 4) Revise discussion of EAEinduced lowering of the threshold for mechanical allodynia according to your findings and relate those to the previous literature.
We also note the following points that need to be addressed in the revised version.
-Provide a list of abbreviations.
-In accordance with EJN policy, please replace bar charts with more informative scatter plots, bar charts or similar.
-Indicate how the mice killed.
-How was 'percentage of white matter infiltrated' measured?
-Provide details of secondary antibodies.
-The English needs some improvement e.g. '..we induced EAE IN mice' Please carefully proof-read.
-Include statistical data in the text as well as the legends and enure it adheres to EJN guidelines, notably report precise P values.
When revising the manuscript, please embolden or underline major changes to the text so they are easily identifiable and please don't leave 'track change' formatting marks in your paper. Please ensure that you provide a text and a figure file for the Graphical Abstract (as detailed in the instructions below Reviewer: 1
Comments to the Author
In this paper the authors examined the role of ASIC2 in the mouse model of experimental autoimmune encephalomyelitis (EAE) and autoptic human brain samples of controls and MS subjects. By using ASIC1 and ASIC2 knockout mice, they confirmed the role of ASIC1 in reducing the clinical score in EAE, already known in the scientific literature, but they also found that ASIC2 also plays a partial role in EAE. They also assessed pain thresholds in these knockout mice and showed that, in physiological conditions, ASIC2 is involved in pain processing. Moreover, they showed that ASIC2 mRNA levels are increased in human brain samples.
Finally, by using an in vitro luciferase reporter gene assay, they assessed whether ASIC2 expression is under miRNA regulation. On page 5, line 13, Jensen et al., is repeated twice and one can be deleted.
On page 7, line 17, I guess it is "mice" instead of "rats"
Reviewer: 2
Comments to the Author This study investigates the involvement of acid-sensing ion channels (ASICs), specifically ASIC1 and ASIC2, in some aspects of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). The authors show that the onset of the clinical phenotype of EAE is delayed in ASIC1(-/-) mice, and that the clinical score is slightly smaller in ASIC2(-/-) mice as compared to WT during the time window of day20-23.
At day 45, the infiltration by MCHII-, CD4+-and CD8+-cells measured from spinal cord slices was significantly lower in ASIC1(-/-) but not ASIC2(-/-) when compared to WT. Before EAE induction, ASIC2(-/-) mice showed a higher threshold for mechanical allodynia than WT and ASIC1(-/-) mice. EAE induction led to significant lowering of this threshold in all genotypes, and there was no significant difference between genotypes in this regard. Analysis of ASIC2a mRNA expression from post mortem brain tissue of MS patients and controls showed a higher expression of ASIC2a mRNA in MS patients. The authors also mention their analysis of the involvement of variants in the ASIC2 UTR region on ASIC2 expression that was however not conclusive, and they provide in a cellular assay indirect evidence for a regulation of ASIC2 by miRNAs. This study shows different pieces of information concerning the relationship between ASICs and EAE in mice, and ASIC2 and MS in humans, that are potentially interesting, but are somewhat isolated from each other, are not sufficiently detailed and don't make a logical, coherent story together. The work appears technically sound except for one aspect that needs to be clarified (point 2), and it adheres to the scope of this journal.
Major points 1. The authors try to focus in this study on ASIC2, since they have previously shown an association between a variant in the ASIC2 UTR and MS, and because there has been more research on the connection between MS/EAE and ASIC1, mostly by the laboratory of Lars Fugger. However, the results of the present study also point more strongly to ASIC1 (confirmation of delayed onset of EAE, infiltration in spinal cord). Based on these findings, it is not logical that the authors analyze the mRNA expression of ASIC2, but not ASIC1, in brain tissue of MS patients and controls. They were motivated to go in this direction by their previous finding of the association between MS and ASIC2, as mentioned above. It seems that in the present manuscript, on a different population than in the previously published study, this association could not be confirmed, however, the analysis is not even shown. The logics of the study asks for providing also the ASIC1 mRNA expression data, and to show the analysis of the association of MS with the different ASIC2a UTR variants.
The authors need to find a way of presenting a coherent, logical manuscript. This may also be possible by further developing the analysis of the regulation by mi-RNA.
2. For the two types of behavioral experiment, the clinical signs of EAE, and the mechanical allodynia, it is critical that the researchers carrying out the experiment are blinded to the genotype of the animal. There is however no mention of this in the Methods. The authors need to state in the methods whether the experimenters were blinded to the mouse genotype or not.
3. The mechanical allodynia experiments showed a higher threshold for ASIC2(-/-) mice than others under control conditions, and a lowering of the threshold by EAE in all three genotypes. There is no evidence provided for a statistically different effect of EAE on mechanical allodynia between genotypes. In the discussion (upper part of p.14) this observation is discussed as if the EAE-induced lowering of the threshold for mechanical allodynia was different in ASIC2(-/-) mice as compared to WT. This is however not shown. In the discussion of the increased threshold in ASIC2(-/-) mice under control conditions (discussion on lower part of p13), the authors should also mention studies that have carried out the same type of experiments (von Frey filaments on hind paw) and did not observe any difference between ASIC2(-/-) and WT, as for example Staniland et al., Eur J Pain (2009), and they should discuss possible reasons for this difference.
Specific points 1. The final statement of the abstract is too strong; the data provide only a weak support for a role of ASIC2 in MS.
2. P3, center of page, "ASIC2….involved in neurodegeneration in C. elegans…". This statement is wrong, degenerins, not ASIC2a are involved in neurodegeneration in C. elegans.
3. P5, lower part of first paragraph, "…showed that 4-aminopyridine, …inhibits heterotrimeric ASIC channels". This information should not be pushed too much as an evidence for an involvement of ASICs in MS, since clinical concentrations of 4-aminopyridine reached in MS therapy are below 1 microM, and the IC50 for ASIC inhibition by 4-aminopyridine is close to 1 mM.
4. P12, top paragraph, analysis of rs28936 genotype link to MS; this analysis should be shown.
P15, upper half, "
The induction of has-miR-27a…" This statement and much of this paragraph needs to be declared more clearly as a hypothesis/speculation.
6. P15, bottom, "The increased pain thresholds in mice……suggests a possible role of ASIC2a in the pathophysiology of MS…". It is not correct to use results of the mechanical allodynia as an argument for an involvement of ASIC2 in EAE or MS. The study in its present form does not show evidence for a difference between ASIC2(-/-) mice and WT in EAE-induced pain.
7. Table 1 , title of the 4th column from left, "AA construct, Dicer.." should probably be "GG construct, Dicer.."
8. The introduction and discussion are very long and should be shortened.
Reviewer: 3
Comments to the Author 
Minor
Page 2 row 4. Specify that "rs28936" refers a Single Nucleotide Polymorphisms.
Page 4 row 2. They talk about the role of ASIC2a but they never mention the characteristics and functions of the ASIC2b subunit.
Page 5 row 7. Why do they use lowercase letters in "Asic1"?
Page 11 row 12. The significant increase of CD4+ in the Asic2 -/ -mice is not mentioned
Page 11 row 19. Why do they use lowercase letters in "Asic1"?
Page 13 row 15. They do not discuss the increase of CD4+ that is observed in the infiltrate present in Asic2
-/ -mice.
Page 15 row 24. Specify "The increased pain thresholds in Asic2-/-mice" We are very grateful to the reviewers for their helpful feedback on this manuscript.
Prof. Luisa Bernardinelli
In accordance with the EJN policy:
-List of abbreviation is provided at the end of the manuscript; -Graph of Figure 5 has been changed; Below we discuss the Reviewers' comment in a point-by-point fashion.
Reviewer #1:
Figure 2 can be combined with Figure 1 as they show results on ASIC2 knockout mice in EAE.
We produced a new figure called Figure 1 comprising On page 7, line 17, I guess it is "mice" instead of "rats". Done.
Reviewer #2:
Major points: We added a specific paragraph in material and methods named "Workflow of the study", in which we specify the logic followed to plan our experiments.
We have now reported in the methods section that the behavioral experiments were performed by an unbiased method carried out by an expert experimenter aware of the mouse genotype.
We agree with the reviewer and we modified the discussion accordingly and added the suggested reference. Smith and ourselves. Although the three reviewers consider that you have satisfactorily addressed most of their concerns, a critical issue remains in the study design. The fact that the behavioral analyses were not achieved in a blinded fashion is a serious concern that goes against the level of rigor and reproducibility expected in EJN publications. You must better validate this choice of not blinding the observers to the mouse genotype and possibly raise this as a major limitation in the discussion of your paper. Alternatively, if you have data that were gathered in a blinded fashion that could corroborate your current findings, these should be included in the paper, to help address this important issue. Editorial re-review of the revised manuscript will be needed.
Additional queries are indicated in the comments below.
When revising the manuscript, please embolden or underline major changes to the text so they are easily identifiable and DO NOT leave 'track change' formatting marks in your paper. Reviewer: 2
Comments to the Author
The authors indicate in the revised manuscript that the experimenter of the behavioral studies with mice (clinical evaluation of neuronal signs in EAE, assessment of mechanical allodynia), was not blinded to the genotype of the mouse under study. To my understanding, it is standard practice to have a blinded experimenter in such types of behavioral experiments. In my view, the results loose in this case much of their value. The journal has to decide whether it accepts results from such analyses that were obtained by an experimenter who knew the mouse genotype. I check "minor revision" as recommendation, but consider it critical that the editor decides whether to accept these mouse data or not.
For the rest, the authors have clarified the logic underlying their study. The analysis of the association between rs28936 and MS in the brain samples remains somewhat unsatisfactory, since it is not possible to confirm here this association that was found in the previous study. There are still some language issues that can be corrected by the authors or editorial team.
Comments to the Author After carefully reading I found that authors have significantly improved the manuscript, following all the review comments. I consider the manuscript has much more coherence and adequate presentation, so I recommend its publication. We are very glad to have satisfactorily addressed most of the Editor's and Reviewer's concerns.
As to the critical issue concerning the blinded behavioral analyses, we apologize with both the Editor and the Reviewer, that despite the experiments were carried out by an experimenter unaware (blinded) of mouse genotype, it was mistakenly reported "aware" in the manuscript. This has now been corrected in our final version of the manuscript.
We apologize again for the inconvenience caused.
Best regards,
Prof. Luisa Bernardinelli
